Targeted Medical Pharma, Inc. (OTCMKTS:TRGM – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. Targeted Medical Pharma shares last traded at $0.00, with a volume of 0 shares traded.
Targeted Medical Pharma Stock Down 100.0 %
About Targeted Medical Pharma
Targeted Medical Pharma, Inc, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy.
Further Reading
- Five stocks we like better than Targeted Medical Pharma
- P/E Ratio Calculation: How to Assess Stocks
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- CarMax Gets in Gear: Is Now the Time to Buy?
- Top Stocks Investing in 5G Technology
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Targeted Medical Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Targeted Medical Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
